Global Malaria Vaccines Market, By Vaccines Type (Pre-Erythrocytic Vaccine, Erythrocytic Vaccine, Multi-antigen Vaccine), Agent (Plasmodium Falciparum, Plasmodium Vivax), Distribution Channel (Hospitals, Clinics, Community Centers), and Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Malaria Vaccines – Paving the Way for a Malaria-free World

Nearly half of the global population is at risk of malaria as per stats released by the World Health Organization (WHO). This in turn has led to increased inclination of various healthcare agencies towards addressing this major malady. Global non-profit organizations such as the Melinda Gates Foundation and PATH are working towards developing preventive measures and saving lives of many in the malaria affected regions. Africa accounts for the largest number of malaria cases and hence, this region is the primary target of launching the first malaria vaccine developed by GlaxoSmithKline plc. Mosquirix received EU approval in 2015 and is presently being examined in Africa as a pilot study.

People in Africa use insecticide-treated mosquito nets and indoor-insecticide spraying for prevention against malarial vectors. Use of insecticide-treated mosquito nets in Africa increased by 80% during 2010-2015 (WHO). Moreover, a number of mosquito repellent products (patches, creams, coils, mats, liquids, etc.) are marketed globally. Besides, non-profit organizations provide cheap and often free treatment facilities to the malarial affected population in Africa. Also, GSK has pledged to sell the vaccines at a much lower cost forgoing its huge profit margins to support the global malaria eradication programs. Furthermore, with more malarial vaccines under research pipeline, the malaria vaccines market is poised for significant growth in near future.

The global malaria vaccines market is expected to be valued at US$ 8.5 million in 2018 and is expected to witness a CAGR of 102.8% during the forecast period (2018 – 2024).

Figure 1. Global Malaria Vaccines Market, Product Pipeline

malaria vaccines market

Source: Coherent Market Insights Analysis (2017)

Tremendous potential in the malaria vaccines market

Potential for malaria vaccines is estimated to be huge as a large share of population, 90%-95%, at risk of infection in Africa and South East-Asia. Advent of vaccines for adult population, would be a major breakthrough for the malaria vaccines market. Below are certain alarming statistics that embarks the need for a malaria vaccine:

  • Artemisinin resistance has been detected in five countries – Laos, Cambodia, Myanmar, Vietnam and Thailand
  • Resistance to P. falciparum parasite against the most available anti-malarial medicines is being reported
  • According to the National Vector Borne Disease Control Programme, nearly 95% of the population in India reside in malaria endemic areas
  • There were an estimated 214 million malaria cases globally in 2015 (WHO)
  • Africa is the most affected region with 90% of malarial deaths in 2015 reported in Africa (WHO)
  • Pregnant women, children below 5 years of age, and tourists from countries with low incidence rate of malaria are identified as the most susceptible target population for malaria

The global malaria vaccines market is expected to experience a huge trajectory growth with the launch of first malarial vaccine in near future.

Increasing accessibility and government support to contribute towards the malaria vaccines market growth

The WHO has established a Global Technical Strategy for Malaria 2016-2030 (GTS) in 2015 with certain defined goals, one of them aimed at eliminating malaria in at least 10 countries. Similarly, the Indian government has established Drug Distribution Centers (DDCs) and Fever Treatment Depots (FTDs) in the rural areas for providing easy access to anti-malarial drugs. Regular monitoring and surveillance by various government programs has helped to reduce malarial cases in India from 2.03 million in 2010 to 1.1 million in 2015. Support from such national and global initiatives will drive malaria vaccines market growth during the forecast period.

Many such non-profit organizations and pharmaceutical companies are conducting research on malaria vaccines. Approximately 31 trials are under progress for malaria vaccine development with a few being blood stage projects. Availability of funds and government support programs will encourage commercialization of product with successful trial results, thus boosting the malaria vaccines market growth trajectory.

The P. falciparum vaccines market is projected to be the growth driver with major vaccine candidates targeting this parasite. Revenues through community centers is projected to be high as demand for preventive treatment methods is high from this end-user segment.

Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes. In 2009, according to WHO, 214 Mn to 397 Mn clinical malaria cases were reported worldwide. However, high estimates of around 515 Mn clinical cases of P. falciparum were projected in 2002. Furthermore, malaria accounted for around 3% of the world’s total Disability Adjusted Life Years (DALYs) lost and around 10% in Africa alone. According to Centers for Disease Control and Prevention (CDC), there are around 156 types of Plasmodium species that infect various species of vertebrates. Among the numerous plasmodium species, four are considered true parasites of humans, as they utilize humans almost exclusively as a natural intermediate host: P. falciparum, P. vivax, P. ovale and P. malariae. Over 85% of malaria mortality is due to P. falciparum. Around 90% of deaths caused by malaria in Sub-Saharan Africa is primarily due to P. falciparum.

Market Dynamics

The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the market for malaria vaccines market. According to World Health Organization (WHO), in 2015, approximately 292,000 children in Africa died of malaria, at very early age of 5 years. Around 306,000 fatalities associated with malaria were reported worldwide in 2015, out of which around 90% cases were reported in Africa. According to World Health Organization (WHO), first global malaria vaccines will be piloted in the regions of sub-Saharan Africa in 2018, with the funding to around US$ 15 Mn. The program is partly funded by the Bill & Melinda Gates Foundation and African Research Centers. Major regions affected by malaria do not have an appropriate healthcare infrastructure and standard economic conditions, due to which they are unable to pay for the better treatments and drugs. Malaria is common in sub-Saharan and African region, due to poor sanitation and healthcare standards. However, the vaccine is being developed by GSK at their lab in Belgium in collaboration with Path, which is an international non-profit organization. This ensures the cost effectiveness of the vaccine though it has taken around 30 years to develop at a cost of US$ 565 Mn. The company pledges not to make a profit from sales of the vaccine and adheres to the price range of around US$ 5 per shot.

Market Taxonomy

This report segments the global malaria vaccines market on the basis of vaccines type, by agent, distribution channel, and geography. On the basis of vaccines type, the malaria vaccines market is categorized into Pre-Erythrocytic Vaccine, Erythrocytic Vaccine and Multi-antigen Vaccine. On the basis of agent, the malaria vaccines market is categorized into Plasmodium Falciparum and Plasmodium Vivax. On the basis of distribution channel, the malaria vaccines market is categorized into hospital, clinics, and community centers. For comprehensive understanding of market dynamics, the global malaria vaccines market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

  • This report provides in-depth analysis of the malaria vaccines and is its use, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2024, considering 2018 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global malaria vaccines market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, Distribution Channel strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd., Sumaya Biotech and GenVec Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
  • The global malaria vaccines market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for malaria vaccines market, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the malaria vaccines market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Malaria Vaccines Market, By Vaccines Type:
    • Pre-Erythrocytic Vaccine
    • Erythrocytic Vaccine
    • Multi-antigen Vaccine
  • Global Malaria Vaccines Market, By Agent:
    • Plasmodium Falciparum
    • Plasmodium Vivax
  • Global Malaria Vaccines Market, By Distribution Channel:
    • Hospitals
    • Clinics
    • Community Centers
  • Global Malaria Vaccines Market, By Geography:
    • North America
      • U.S.
        • U.S. Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • U.S. Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • U.S. Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Canada
        • Canada Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Canada Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Canada Malaria Vaccines Market, By Distribution Channel :
          • Hospitals
          • Clinics
          • Community Centers
    • Europe
      • U.K.
        • Europe Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Europe Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Europe Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Germany
        • Germany Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Germany Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Germany Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Italy
        • Italy Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Italy Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Italy Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • France
        • France Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • France Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • France Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Spain
        • Spain Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Spain Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Spain Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Russia
        • Russia Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Russia Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Russia Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Rest of Europe
        • Rest of Europe Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Rest of Europe Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Rest of Europe Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
    • Asia-Pacific
      • China
        • China Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • China Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • China Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • India
        • India Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • India Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • India Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Japan
        • Japan Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Japan Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Japan Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • ASEAN
        • ASEAN Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • ASEAN Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • ASEAN Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
          •  
      • Australia
        • Australia Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Australia Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Australia Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • South Korea
        • South Korea Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • South Korea Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • South Korea Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Rest of Asia Pacific
        • Rest of Asia Pacific Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Rest of Asia Pacific Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Rest of Asia Pacific Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
    • Latin America
      • Brazil
        • Brazil Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Brazil Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Brazil Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Mexico
        • Mexico Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Mexico Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Mexico Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Rest of Latin America
        • Rest of Latin America Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Rest of Latin America Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Rest of Latin America Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
    • Middle East
      • GCC
        • GCC Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • GCC Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • GCC Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Israel
        • Israel Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Israel Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Israel Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Rest of Middle East
        • Rest of Middle East Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Rest of Middle East Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Rest of Middle East Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
    • Africa
      • North Africa
        • North Africa Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • North Africa Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • North Africa Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • Central Africa
        • Central Africa Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • Central Africa Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • Central Africa Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
      • South Africa
        • South Africa Malaria Vaccines Market, By Vaccines Type:
          • Pre-Erythrocytic Vaccine
          • Erythrocytic Vaccine
          • Multi-antigen Vaccine
        • South Africa Malaria Vaccines Market, By Agent:
          • Plasmodium Falciparum
          • Plasmodium Vivax
        • South Africa Malaria Vaccines Market, By Distribution Channel:
          • Hospitals
          • Clinics
          • Community Centers
  • Company Profiles
    • GlaxoSmithKline plc *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Sanaria Inc.
    • Nobelpharma Co., Ltd.
    • Sumaya Biotech
    • GenVec, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Vaccines Type
      • Market Snippet By Agent
      • Market Snippet By Distribution Channel
      • Market Snippet By Geography
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • PEST Analysis
    • Key Market Developments
    • Product Pipeline Analysis
    • RTS, S Development Roadmap
  4. Global Malaria Vaccines Market, By Vaccines Type, 2018 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, 2018 - 2024
      • Segment Trends
    • Pre-Erythrocytic Vaccine
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2018 - 2024, (US$ Million)
    • Erythrocytic Vaccine
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2018 - 2024, (US$ Million)
    • Multi-antigen Vaccine
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2018 - 2024, (US$ Million)
  5. Global Malaria Vaccines Market, By Agent, 2018 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, 2018 - 2024
      • Segment Trends
    • Plasmodium Falciparum
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2018 - 2024, (US$ Million)
    • Plasmodium Vivax
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2018 - 2024, (US$ Million)
  6. Global Malaria Vaccines Market, By Distribution Channel, 2018 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, 2018 - 2024
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2018 - 2024, (US$ Million)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2018 - 2024, (US$ Million)
    • Community Centers
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2018 - 2024, (US$ Million)
  7. Global Malaria Vaccines Market, By Geography, 2018 - 2024 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, For Regions, 2018 - 2024
    • North America
      • Market Share Analysis, By Country, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2018 - 2024
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
    • Europe
      • Market Share Analysis, By Country, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2018 - 2024
        • U.K.
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Germany
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • France
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Spain
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Rest of Europe
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
    • Asia Pacific
      • Market Share Analysis, By Country, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2018 - 2024
        • China
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • India
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Rest of Asia Pacific
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
    • Latin America
      • Market Share Analysis, By Country, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2018 - 2024
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Argentina
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Rest of Latin America
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
    • Middle East
      • Market Share Analysis, By Country, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2018 - 2024
        • GCC Countries
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Rest of Middle East
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
    • Africa
      • Market Share Analysis, By Country, 2018 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2018 - 2024
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Vaccines Type, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Agent, 2018 - 2024 (US$ Million)
          • Market Size and Forecast, By Distribution Channel, 2018 - 2024 (US$ Million)
  8. Competitive Landscape
    • Company Profiles
      • GlaxoSmithKline plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Sanaria Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Nobelpharma Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Sumaya Biotech
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • GenVec, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 28 market data tables and 24 figures on "Malaria Vaccines Market - Global forecast to 2024”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.